# Matinas BioPharma Holdings, Inc. (MTNB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MTNB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.92M | $ -1.60M | $ 1.19M | $ 3.02M |
| 2025 | $ 0 | $ -11.23M | $ -7.18M | $ 1.35M | $ 4.83M |
| 2024 | $ 0 | $ -25.49M | $ -16.70M | $ 2.89M | $ 7.59M |
| 2023 | $ 1.19M | $ -24.81M | $ -16.76M | $ 3.56M | $ 19.25M |
| 2022 | $ 3.56M | $ -23.46M | $ -22.39M | $ 4.12M | $ 36.64M |
| 2021 | $ 39.2K | $ -27.68M | $ -18.40M | $ 4.70M | $ 52.49M |
| 2020 | $ 201.7K | $ -28.60M | $ -22.13M | $ 3.75M | $ 63.73M |
| 2019 | $ 0 | $ -22.42M | $ -18.71M | $ 4.23M | $ 33.05M |
| 2018 | $ 0 | $ -18.60M | $ -721.41M | $ 390.7K | $ 16.14M |
| 2017 | $ 201.6K | $ -20.86M | $ -16.71M | $ 264.9K | $ 10.68M |
| 2016 | $ 3.13M | $ -10.45M | $ -8.42M | $ 144.4K | $ 7.15M |
| 2015 | $ 0 | $ -12.83M | $ -11.08M | $ 11.3K | $ 6.07M |
| 2014 | $ 0 | $ -14.44M | $ -11.66M | $ 59.7K | $ 2.23M |
| 2013 | $ 0 | $ -5.28M | $ -4.38M | $ 0 | $ 10.47M |
| 2012 | $ 0 | $ -149.4K | $ -82.7K | $ 0 | $ 339.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.39 |
| Liabilities / Eq | 0.94 |
| Current Ratio | 1.32 |

## Other views

- [Metrics](https://sponda.capital/en/MTNB.md)
- [Charts](https://sponda.capital/en/MTNB/charts.md)
- [Compare](https://sponda.capital/en/MTNB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.